Papers by Kostas Pantopoulos
Methods in Enzymology, 2002
Publisher Summary Iron regulatory protein 1 (IRP1) posttranscriptionally controls the expression ... more Publisher Summary Iron regulatory protein 1 (IRP1) posttranscriptionally controls the expression of proteins implicated in iron and energy metabolism. IRE/IRP1 interactions modulate mRNA translation or stability and result in homeostatic adaptations to changes in iron availability. IRP1 belongs to the family of iron–sulfur isomerases. Its genetic activity is regulated by the iron dependent assembly–disassembly of a cubane, aconitase-type [4Fe–4S] cluster. Direct administration of hydrogen peroxide to cells leads to a rapid activation of IRP1 to its IRE-binding form—IRPI activation. This chapter describes the basic methods that have been developed and applied to study the activation of IRPI by hydrogen peroxide. These include the electrophoretic mobility shift assay to detect IRE-binding activity, the chemiluminescence luminol/hypochlorite assay to detect extracellular hydrogen peroxide, the method for enzymatic generation of hydrogen peroxide at steady-state levels, and the fluorometric assay to monitor relative intracellular hydrogen peroxide levels. In addition, the chapter describes key experiments that have provided insights regarding the mechanism and the physiological implications of IRP1 activation by hydrogen peroxide in cultured B6 fibroblasts, in permeabilized B6 fibroblasts, and in the intact rat liver.
Journal of Acquired Immune Deficiency Syndromes, Jun 27, 2023
Wiley-VCH Verlag GmbH eBooks, Jan 2, 2008
Hepatology communications, Jul 16, 2021
Hepcidin is a liver‐derived peptide hormone that limits iron egress from tissues to the bloodstre... more Hepcidin is a liver‐derived peptide hormone that limits iron egress from tissues to the bloodstream. It operates by binding to the iron exporter ferroportin, which blocks iron transport and tags ferroportin for degradation. Genetic hepcidin inactivation leads to hereditary hemochromatosis, a disease of iron overload. We used wild‐type and Hjv‐/‐ mice, a model of hemochromatosis, to examine the expression of ferroportin and other proteins of iron metabolism in hepcidin target tissues. The animals were previously subjected to dietary iron manipulations. In Hjv‐/‐ mice, hepcidin messenger RNA correlated significantly with hepatic iron load (r = 0.8211, P < 0.001), but was substantially lower compared with wild‐type controls. Duodenal ferroportin and divalent metal transporter 1 (DMT1), as well as splenic and hepatic ferroportin, were overexpressed in these animals. A high‐iron diet (2% carbonyl iron) suppressed duodenal DMT1 levels in both wild‐type and Hjv‐/‐ mice; however, it did not affect duodenal ferroportin expression in Hjv‐/‐ mice, and only reduced it in wild‐type mice. In contrast, the high‐iron diet decreased splenic ferroportin exclusively in Hjv‐/‐ mice, whereas it induced hepatic ferroportin exclusively in wild‐type mice. Conclusion: Our data show that dietary iron differentially affects ferroportin expression in mouse tissues and are consistent with hepcidin‐dependent and hepcidin‐independent mechanisms for ferroportin regulation. In the Hjv‐/‐ mouse model of hemochromatosis, duodenal ferroportin remains unresponsive to iron but DMT1 is appropriately iron‐regulated.
Despite advances in our knowledge and attempts to improve therapies, β-thalassemia remains a prev... more Despite advances in our knowledge and attempts to improve therapies, β-thalassemia remains a prevalent disorder with increased risk for the development of cardiomyopathy. Using an untargeted discovery-based lipidomic workflow, we uncovered that transfusion-dependent thalassemia (TDT) patients had a unique circulating lipidomic signature consisting of 387 lipid features, allowing their significant discrimination from healthy controls (Q-value < 0.01). In particular, TDT patients had elevated triacylglycerols and long-chain acylcarnitines, albeit lower ether phospholipids or plasmalogens, sphingomyelins, and cholesterol esters, reminiscent of that previously characterized in cardiometabolic diseases resulting from mitochondrial and peroxisomal dysfunction. Discriminating lipid (sub)classes correlated differentially with clinical parameters, reflecting blood (ether phospholipids) and iron (cholesterol ester) status or heart function (triacylglycerols). We also tested 15 potential se...
Scientific Reports
An amendment to this paper has been published and can be accessed via a link at the top of the pa... more An amendment to this paper has been published and can be accessed via a link at the top of the paper.
PLOS ONE
Hepcidin is an iron regulatory peptide hormone that is secreted from hepatocytes and inhibits iro... more Hepcidin is an iron regulatory peptide hormone that is secreted from hepatocytes and inhibits iron efflux from tissues to plasma. Under inflammatory conditions, hepcidin is transcriptionally induced by IL-6/STAT3 signaling and promotes hypoferremia, an innate immune response to infection. If this pathway remains unresolved, chronic overexpression of hepcidin contributes to the anemia of inflammation, a common medical condition. Previous work showed that carbon monoxide (CO) releasing drugs (CORMs) can attenuate inflammatory induction of hepcidin. Because CO is physiologically generated during heme degradation by heme oxygenase 1 (HO-1), an IL-6-inducible enzyme with anti-inflammatory properties, we hypothesized that hepatocellular HO-1 may operate as a physiological feedback regulator of hepcidin that resolves inflammatory signaling. To address this, we generated and analyzed hepatocyte-specific HO-1 knockout (Hmox1 Alb-Cre) mice. We show that these animals mount appropriate hepcidin-mediated hypoferremic response to LPS-induced inflammation, with kinetics similar to those of control Hmox1 fl/fl mice. Likewise, primary hepatocytes from Hmox1 Alb-Cre and Hmox1 fl/fl mice exhibit similar degree and kinetics of hepcidin induction following IL-6 treatment. We conclude that hepatocellular HO-1 has no physiological function on hepcidin regulation by the inflammatory pathway.
ABSTRACT Iron is an essential nutrient but also a potential biohazard. Elaborate homeostatic mech... more ABSTRACT Iron is an essential nutrient but also a potential biohazard. Elaborate homeostatic mechanisms have evolved to regulate dietary iron absorption at levels sufficient to satisfy metabolic needs and prevent the accumulation of metal excess. Internalized dietary iron enters the pool of plasma transferrin for delivery into the erythron and other tissues. Nevertheless, in healthy adults, the daily contribution of dietary iron for erythropoiesis is minimal and the vast majority of circulating transferrin-iron derives from macrophages, that eliminate senescent red blood cells and recycle their iron. Cellular iron uptake is mediated by endocytosis of iron-loaded transferrin upon binding to its transferrin receptor 1 (TfR1). Excess of intracellular iron that is not required for metabolic purposes is stored within ferritin. The expression of TfR1 and ferritin is coordinately and reciprocally controlled by a post-transcriptional mechanism. This involves two cytoplasmic iron regulatory proteins (IRP1 and IRP2), which interact with the iron responsive elements (IREs) of TfR1 and ferritin mRNAs. IRE/IRP interactions that occur in iron-deficient cells, stabilize TfR1 mRNA and inhibit ferritin mRNA translation. In iron-replete cells, IRP1 assembles an aconitase-type [4Fe-4S] 2+ cluster, which precludes IRE-binding. By contrast, IRP2 undergoes iron-dependent proteasomal degradation following ubiquitination. IRPs control the expression of additional mRNAs and respond not only to cellular iron levels but also to other stimuli, such as oxygen, oxidative stress and nitric oxide. The targeted disruption of both IRP1 and IRP2 in mice is associated with early embryonic lethality, underlying the physiological significance of the IRE/IRP regulatory system. While the ablation of IRP1 alone does not manifest any discernible pathology, IRP2(-/-) mice exhibit microcytic anemia and neurological defects. The ongoing development of mouse strains with spatial and temporal disruption of IRPs is providing further insight on their physiological functions.
Haematologica, 2016
We agree with the comments of Kontoghiorghe et al. l on the effects of various dietary and pharma... more We agree with the comments of Kontoghiorghe et al. l on the effects of various dietary and pharmacological factors in iron absorption. There is no doubt that lipophilic iron compounds can be relatively efficiently absorbed by the gastrointestinal tract, while hydrophilic iron complexes are impermeable to cellular membranes. Nevertheless, even though heme shares some physicochemical similarities to other lipophilic iron-binding compounds, it is a molecule with distinct and unique biological properties. Thus, gastrointestinal absorption, 2 intracellular transport 3 and extracellular neutralization 4 of heme are mediated by specific pathways. Moreover, heme can only release iron in cells following its enzymatic degradation by heme oxygenases. 5 As Kontoghiorghe et al. point out, and as is also demonstrated by epidemiological data, 6 iron deficiency anemia is quite common in vegetarian and malnourished populations of developing countries, but is not frequently observed in Western populations consuming heme-rich diets. Consistently, nutritional studies have suggested that heme iron is more bioavailable to humans than inorganic iron. 7 We showed that heme is a poor dietary iron source for mice. 8 which is in line with the fact that these animals are not predators and rarely have access to hemerich sources of nutrition. We identified the rate-limiting step in the transport of luminal heme across the apical membrane of murine enterocytes. Based on these findings, we speculated that efficient heme absorption mechanisms may have evolved preferentially in carnivores and omnivores, and not in de facto vegetarian species. Future identification of the long-sought intestinal heme transporter(s) could provide experimental support to this hypothesis, if this molecule is differentially expressed in human and murine enterocytes.
Journal of Biological Chemistry, 1999
Iron regulatory protein-1 (IRP-1) controls the expression of several mRNAs by binding to iron-res... more Iron regulatory protein-1 (IRP-1) controls the expression of several mRNAs by binding to iron-responsive elements (IREs) in their untranslated regions. In ironreplete cells, a 4Fe-4S cluster converts IRP-1 to cytoplasmic aconitase. IRE binding activity is restored by cluster loss in response to iron starvation, NO, or extracellular H 2 O 2. Here, we study the effects of intracellular quinone-induced oxidative stress on IRP-1. Treatment of murine B6 fibroblasts with menadione sodium bisulfite (MSB), a redox cycling drug, causes a modest activation of IRP-1 to bind to IREs within 15-30 min. However, IRE binding drops to basal levels within 60 min. Surprisingly, a remarkable loss of both IRE binding and aconitase activities of IRP-1 follows treatment with MSB for 1-2 h. These effects do not result from alterations in IRP-1 half-life, can be antagonized by the antioxidant N-acetylcysteine, and regulate IREcontaining mRNAs; the capacity of iron-starved MSBtreated cells to increase transferrin receptor mRNA levels is inhibited, and MSB increases the translation of a human growth hormone indicator mRNA bearing an IRE in its 5-untranslated region. Nonetheless, MSB inhibits ferritin synthesis. Thus, menadione-induced oxidative stress leads to post-translational inactivation of both genetic and enzymatic functions of IRP-1 by a mechanism that lies beyond the "classical" Fe-S cluster switch and exerts multiple effects on cellular iron metabolism.
FEBS Letters, 2011
Iron regulatory protein 2 (IRP2) is a critical switch for cellular and systemic iron homeostasis.... more Iron regulatory protein 2 (IRP2) is a critical switch for cellular and systemic iron homeostasis. In iron-deficient or hypoxic cells, IRP2 binds to mRNAs containing iron responsive elements (IREs) and regulates their expression. Iron promotes proteasomal degradation of IRP2 via the F-box protein FBXL5. Here, we explored the effects of oxygen and cellular redox status on IRP2 stability. We show that iron-dependent decay of tetracycline-inducible IRP2 proceeds efficiently under mild hypoxic conditions (3% oxygen) but is compromised in severe hypoxia (0.1% oxygen). A treatment of cells with exogenous H 2 O 2 protects IRP2 against iron and increases its IRE-binding activity. IRP2 is also stabilized during menadione-induced oxidative stress. These data demonstrate that the degradation of IRP2 in iron-replete cells is not only oxygen-dependent but also sensitive to redox perturbations.
European Journal of Clinical Investigation, 2004
Background Iron regulatory protein 1 (IRP1), a post-transcriptional regulator of iron metabolism,... more Background Iron regulatory protein 1 (IRP1), a post-transcriptional regulator of iron metabolism, is activated in the duodenum of iron-deficient animals, which is associated with increased iron absorption. In cell cultures IRP1 was also activated by iron-independent signals, such as H 2 O 2. Here we investigate whether luminal perfusion of rat duodenum with H 2 O 2 activates duodenal IRP1 and modulates duodenal iron absorption. Methods Duodena from iron-adequate Sprague-Dawley rats were luminally perfused with H 2 O 2. Iron regulatory protein-1 activity was determined in duodenal mucosa or in villus and crypt preparations by an electrophoretic mobility shift assay. Duodenal 59 Fe absorption was measured in isolated, perfused duodenal segments ex vivo and in ligated loops in vivo. 59 Fe uptake from the blood side was assessed after i.v. injection of 59 Fe-nitrilotriacetic acid. Results Similar to iron deficiency, the perfusion with 0-50 mM of H 2 O 2 increases duodenal IRP1 activity along the entire crypt villus-axis in a dose-dependent manner. After H 2 O 2 treatment, IRP1 remains activated for 12-24 h in the tips and for 72 h in the crypts. In iron-deficiency, IRP activation correlates with increased 59 Fe absorption. However, the H 2 O 2 treatment fails to stimulate any increase in 59 Fe uptake, without promoting damage of mucosal architecture or impairing glucose and water transport. Conclusion Duodenal 59 Fe uptake is not affected by the H 2 O 2-mediated activation of IRP1.
Biochemical Journal, 2011
Iron is an essential but potentially hazardous biometal. Mammalian cells require sufficient amoun... more Iron is an essential but potentially hazardous biometal. Mammalian cells require sufficient amounts of iron to satisfy metabolic needs or to accomplish specialized functions. Iron is delivered to tissues by circulating transferrin, a transporter that captures iron released into the plasma mainly from intestinal enterocytes or reticuloendothelial macrophages. The binding of iron-laden transferrin to the cell-surface transferrin receptor 1 results in endocytosis and uptake of the metal cargo. Internalized iron is transported to mitochondria for the synthesis of haem or iron–sulfur clusters, which are integral parts of several metalloproteins, and excess iron is stored and detoxified in cytosolic ferritin. Iron metabolism is controlled at different levels and by diverse mechanisms. The present review summarizes basic concepts of iron transport, use and storage and focuses on the IRE (iron-responsive element)/IRP (iron-regulatory protein) system, a well known post-transcriptional regula...
Encyclopedia of Signaling Molecules
Hepatology Communications
PLOS ONE
Hepcidin is a peptide hormone that targets the iron exporter ferroportin, thereby limiting iron e... more Hepcidin is a peptide hormone that targets the iron exporter ferroportin, thereby limiting iron entry into the bloodstream. It is generated in hepatocytes mainly in response to increased body iron stores or inflammatory cues. Iron stimulates expression of bone morphogenetic protein 6 (BMP6) from liver sinusoidal endothelial cells, which in turn binds to BMP receptors on hepatocytes and induces the SMAD signaling cascade for transcriptional activation of the hepcidin-encoding HAMP mRNA. SMAD signaling is also essential for inflammatory HAMP mRNA induction by the IL-6/STAT3 pathway. Herein, we utilized human Huh7 hepatoma cells and primary murine hepatocytes to assess the effects of iron perturbations on signaling to hepcidin. Iron chelation appeared to slightly impair signaling to hepcidin. Subsequent iron supplementation not only failed to reverse these effects, but drastically reduced basal HAMP mRNA and inhibited HAMP mRNA induction by BMP6 and/or IL-6. Thus, treatment of cells wi...
PLOS ONE
Hepatic iron overload, a hallmark of hereditary hemochromatosis, triggers progressive liver disea... more Hepatic iron overload, a hallmark of hereditary hemochromatosis, triggers progressive liver disease. There is also increasing evidence for a pathogenic role of iron in non-alcoholic fatty liver disease (NAFLD), which may progress to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular cancer. Mouse models of hereditary hemochromatosis and NAFLD can be used to explore potential interactions between iron and lipid metabolic pathways. Hfe-/-mice, a model of moderate iron overload, were reported to develop early liver fibrosis in response to a high fat diet. However, this was not the case with Hjv-/-mice, a model of severe iron overload. These data raised the possibility that the Hfe gene may protect against liver injury independently of its iron regulatory function. Herein, we addressed this hypothesis in a comparative study utilizing wild type, Hfe-/-, Hjv-/-and double Hfe-/-Hjv-/-mice. The animals, all in C57BL/6J background, were fed with high fat diets for 14 weeks and developed hepatic steatosis, associated with iron overload. Hfe co-ablation did not sensitize steatotic Hjv-deficient mice to liver injury. Moreover, we did not observe any signs of liver inflammation or fibrosis even in single steatotic Hfe-/-mice. Ultrastructural studies revealed a reduced lipid and glycogen content in Hjv-/-hepatocytes, indicative of a metabolic defect. Interestingly, glycogen levels were restored in double Hfe-/-Hjv-/-mice, which is consistent with a metabolic function of Hfe. We conclude that hepatocellular iron excess does not aggravate diet-induced steatosis to steatohepatitis or early liver fibrosis in mouse models of hereditary hemochromatosis, irrespectively of the presence or lack of Hfe.
Uploads
Papers by Kostas Pantopoulos